Sarcoidosis complicating anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody biotherapy

European Respiratory Journal

Volumn 41, Issue 1, 2013, Pages 246-247

  Tissot, Claire ^a   Carsin, Ania ^b   Freymond, Nathalie ^b   Pacheco, Yves ^b   Devouassoux, Gilles ^a  

^a CROIX ROUSSE HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IPILIMUMAB; PLACEBO;

ADULT; BIOLOGICAL THERAPY; BRONCHUS BIOPSY; CASE REPORT; CD4+ T LYMPHOCYTE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL (TOPIC); CUTANEOUS MELANOMA; HUMAN; LETTER; LUNG ALVEOLITIS; LUNG LAVAGE; LUNG SARCOIDOSIS; LYMPH NODE DISSECTION; MALE; MEDIASTINOSCOPY; MULTIPLE PULMONARY NODULES; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SHOULDER MELANOMA; SKIN BIOPSY; SKIN GRANULOMA;

ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOTHERAPY; LUNG DISEASES; MALE; MIDDLE AGED; SARCOIDOSIS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84872183744     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00107912     Document Type: Letter

References (14)

1. Ramos-Casals M, Mañá J, Nardi N, et al. Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases. Medicine (Baltimore) 2005; 84: 69-80.
2. Baughman RP, Lower EE, Du Bois RM. Sarcoidosis. Lancet 2003; 361: 1111-1118.
3. Wikén M, Ostadkarampour M, Eklund A, et al. Antigen-specific multifunctional T-cells in sarcoidosis patients with Lofgren's syndrome. Eur Respir J 2012; 40: 110-121.
4. Zissel G, Ernst M, Schlaak M, et al. Accessory function of alveolar macrophages from patients with sarcoidosis and other granulomatous and nongranulomatous lung diseases. J Investig Med 1997; 45: 75-86.
5. Weber JS. The clinical utility of cytotoxic T lymphocyte antigen 4 abrogation by human antibodies. Melanoma Res 2006; 16: 379-383.
6. Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with Ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363: 711-723.
7. Maker AV, Phan GQ, Attia P, et al. Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study. Ann Surg Oncol 2005; 12: 1005-1016.
8. Phan GQ, Weber JS, Sondak VK. CTLA-4 blockade with monoclonal antibodies in patients with metastatic cancer: surgical issues. Ann Surg Oncol 2008; 15: 3014-3021.
9. Attia P, Phan GQ, Maker AV, et al. Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J Clin Oncol 2005; 23: 6043-6053.
10. Eckert A, Schoeffler A, Dalle S, et al. Anti-CTLA4 Monoclonal antibody induced Sarcoidosis in a metastatic melanoma patient. Dermatology 2009; 218: 69-70.
11. Wilgenhof S, Morlion V, Seghers AC, et al. Sarcoidosis in a patient with metastatic melanoma sequentially treated with anti-CTLA-4 monoclonal antibody and selective BRAF inhibitor. Anticancer Res 2012; 32: 1355-1359.
12. Nguyen T, Liu XK, Zhang Y, et al. BTNL2, a butyrophilin-like molecule that functions to inhibit t cell activation. J Immunol 2006; 176: 7354-7360.
13. Valentonyte R, Hampe J, Huse K, et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005; 37: 357-364.
14. Cottin V, Müller-Quernheim J. Sarcoidosis from bench to bedside: a state-of-the-art series for the clinician. Eur Respir J 2012; 40: 14-16.